» Articles » PMID: 16027039

TLR3 in Antiviral Immunity: Key Player or Bystander?

Overview
Journal Trends Immunol
Date 2005 Jul 20
PMID 16027039
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Toll-like receptor 3 (TLR3), which recognizes double-stranded (ds)RNA, was the first identified antiviral TLR and, because dsRNA is a universal viral molecular pattern, TLR3 has been assumed to have a central role in the host response to viruses. However, this role has recently been questioned by in vivo studies and the discovery of several other antiviral pattern-recognition receptors. In this review, the function of TLR3 in the context of these other receptors, namely TLR7, 8 and 9 and the newly identified dsRNA-receptor retinoic-acid inducible gene-I (RIG-I) is discussed. Also, recent research concerning the expression profile of TLR3, its evasion by viruses and a potential role in crosspriming is addressed, which reveals a clearer appreciation of the contribution of TLR3 to antiviral immunity.

Citing Articles

Gold nanoparticles as innovative therapeutics for oral mucositis: A review of current evidence.

Choudhury M, Brunton P, Dias G, Schwass D, Meledandri C, Ratnayake J Drug Deliv Transl Res. 2024; .

PMID: 39625578 DOI: 10.1007/s13346-024-01748-x.


Consensus, debate, and prospective on pancreatic cancer treatments.

Wang J, Yang J, Narang A, He J, Wolfgang C, Li K J Hematol Oncol. 2024; 17(1):92.

PMID: 39390609 PMC: 11468220. DOI: 10.1186/s13045-024-01613-x.


MHC class I-dressing is mediated via phosphatidylserine recognition and is enhanced by polyI:C.

Hori A, Toyoura S, Fujiwara M, Taniguchi R, Kano Y, Yamano T iScience. 2024; 27(5):109704.

PMID: 38680663 PMC: 11046299. DOI: 10.1016/j.isci.2024.109704.


Progress towards Adjuvant Development: Focus on Antiviral Therapy.

Brai A, Poggialini F, Pasqualini C, Trivisani C, Vagaggini C, Dreassi E Int J Mol Sci. 2023; 24(11).

PMID: 37298177 PMC: 10253057. DOI: 10.3390/ijms24119225.


Toll-like receptors in cardiac hypertrophy.

Zhang Y, Wu J, Dong E, Wang Z, Xiao H Front Cardiovasc Med. 2023; 10:1143583.

PMID: 37113698 PMC: 10126280. DOI: 10.3389/fcvm.2023.1143583.